Research Type: Extramural
Associate Professor Marina Pajic and her team have identified a molecular pathway that controls communication between pancreatic cancer cells and stromal cells.
Dr Seong Beom Ahn and team’s research aims to change CRC patient clinical management, by being able to provide certainty, clinicians will make better-informed treatment decisions.
Dr Klaartje Somers from Children’s Cancer Institute and Dr Deborah Meyran from Peter MacCallum Cancer Centre, along with their teams, are investigating ways to overcome the challenges of treating solid tumours with CAR T-cell immunotherapy
Recent research has found that androgens (such as testosterone) can activate an important anti-cancer immune response in prostate cancer cells.
Professor Kavallaris and her team aim to dramatically reduce duration of tumour testing programs, with direct benefits to patients from more rapid adoption of recommended treatments.
A/Professor Croucher and his team are investigating new treatment options for triple-negative breast cancers that have spread.
Dr Wang will investigate and detail how leukaemic stem cells are able to survive and renew.
A/Professor Ziegler will test if a new drug combination can switch off the overactive molecular pathway and halt cancer progression in the most aggressive childhood brain tumours.
A/Prof Swarbrick and his team will study multiple solid cancers that have a range of responses to immunotherapy. The team will identify which types of stromal cells block immune responses to cancer and how they do this.